Dana-Farber’s Breast Oncology Center

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Dana-Farber’s Breast Oncology Center
Jun 15, 2025, 03:43 | Blog
Register for the "Breast Cancer: New Horizons, Current Controversies" Course on July 17-18 - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Still time to register for the…
Jun 14, 2025, 15:38 | Blog
Join the webinar to learn about the intersection of aging and Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join Dana-Farber Cancer Institute's Drs. Rachel…
Jun 13, 2025, 07:28 | Science
QoL Findings from PALLAS Trial are Published in ESMO Open - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X about a paper by M.J. Naughton…
Jun 13, 2025, 05:57 | Science
Dana-Farber’s Breast Oncology Center - Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients
Dana-Farber’s Breast Oncology Center posted on X: "New study evaluates the accuracy and reproducibility of…
Jun 9, 2025, 07:43 | Blog
Dana-Farber’s Breast Oncology Center - Novel and Emerging Treatment Options in ER+/HER2− Metastatic Breast Cancer
Dana-Farber’s Breast Oncology Center posted on X: "Check out this video series and hear from…
Jun 6, 2025, 16:29 | Blog
Caterina Sposetti Highlights Support and Mentorship from Dana-Farber’s Breast Oncology Leaders
Caterina Sposetti, Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "With…
Jun 6, 2025, 10:32 | Blog
The Helen Gurley Brown Presidential Summit on Women and Science - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Happening now! The Helen Gurley Brown Presidential…
Jun 5, 2025, 13:30 | Insight
Filipa Lynce Receives Advanced Clinical Research Award in Breast Cancer from Conquer Cancer Foundation
Dana-Farber's Breast Oncology Center shared a post on X: "Congratulations to Dana Farber's Filipa Lynce, MD, FASCO,…
Jun 3, 2025, 16:58 | Insight
Paolo Tarantino Presented DATO-Base Trial Poster at ASCO 2025 on Breast Cancer CNS Metastases
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared on…
Jun 3, 2025, 10:50 | Blog
Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, reshared a post…
May 27, 2025, 10:32 | Blog
Sarah Sammons: Challenging Treatment Paradigms in HER2-Low and HER2-Ultralow MBC
Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post on LinkedIn: "Join me…
May 10, 2025, 21:51 | Blog
Join Dana-Farber’s Breast Oncology Center for a day of finding balance through wellness, education and community
Dana-Farber’s Breast Oncology Center shared a post on X: "Join us in person at Dana-Farber…
May 8, 2025, 10:22 | Blog
Giacomo de Micheli: Grateful for an Inspiring 3-Month Journey at Dana-Farber’s Breast Oncology Center
Giacomo De Micheli, Medical student at Vita-Salute San Raffaele University, shared on X: "Feeling so…
May 7, 2025, 16:59 | Blog
Happy National Nurses Week to Our Expert Infusion Nurses - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Happy National Nurses Week to our…
May 7, 2025, 09:10 | Science
Circulating Tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Solid Tumors Treated with Neoadjuvant ICIs
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out this recent Annals of…
Apr 26, 2025, 13:26 | Blog
Paolo Tarantino: Proud to be awarded a Conquer Cancer ASCO25 Merit Award
Paolo Tarantino, Research Fellow presso Dana-Farber Cancer Institute, shared a post by Dana-Farber’s Breast Oncology…
Apr 19, 2025, 07:03 | Blog
Dana-Farber’s Breast Oncology Center - Meet the Expert: Dr. Adela Rodríguez Hernández
Dana-Farber’s Breast Oncology Center posted on X: "Meet Adela Rodríguez Hernández, MD! She joined Dana…
Apr 14, 2025, 16:49 | Blog
Antonio Giordano’s Novel Work Offers New Hope in the Fight Against Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Dr. Antonio Giordano’s novel work on…
Mar 1, 2025, 08:45 | Blog
Rare Disease Day: Uniting the World for a Common Cause
Every year on the last day of February, the global health community comes together to…
Feb 26, 2025, 16:32 | Science
Clonal Hematopoiesis in Women With Breast Cancer
Dana-Farber’s Breast Oncology Center shared an article led by Christina Mayerhofer on X about the…
Feb 5, 2025, 15:31 | Blog
This year’s World Cancer Day theme emphasizes 'People Centered Care' - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "This year’s World Cancer Day theme…
Feb 4, 2025, 09:30 | Blog
Sarah Sammons: Finally brain MRI screening data in MBC
Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post on X: "Finally…
Jan 30, 2025, 06:06 | Insight
Control choice in acupuncture clinical trials involving patients with breast cancer by Barbara Bierer et al.
On January 23rd, a paper titled "Analysis of the Choice of Control in Acupuncture Clinical…
Jan 25, 2025, 05:02 | Insight
HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis
Dana-Farber’s Breast Oncology Center shared a post on X about a recent paper by F.…
Jan 23, 2025, 02:32 | Blog
The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: "The SATEENtrial led by Dana-Farber’s Breast Oncology Center…
Jan 22, 2025, 18:49 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…
Jan 19, 2025, 07:17 | Science
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al.,…
Jan 17, 2025, 22:17 | Insight
Abstracts are being accepted for the annual Dana-Farber/Harvard Cancer Center Breast and Gynecologic Cancer Symposium
Dana-Farber’s Breast Oncology Center shared a post on X: “Abstracts are now being accepted for…
Jan 15, 2025, 17:18 | Blog
Registration is open for the Research Updates and Advances in Brain Mets webinar - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join Dana Farber's Nancy Lin, MD…
Jan 11, 2025, 11:08 | Blog
Dana-Farber’s Breast Oncology Center - Adrienne Waks receives the George P. Canellos Award for Excellence in Clinical Investigation
Dana-Farber’s Breast Oncology Center shared on X: "Congratulations to Adrienne Waks, Associate Director of Clinical…
Jan 9, 2025, 12:43 | Science
Is Preventative Oophorectomy Safe?
Dana-Farber’s Breast Oncology Center shared a recent article by Megan E. Tesch on X: "Check…
Jan 8, 2025, 17:12 | Blog
The use of Cold Caps in preventing Hair Loss with novel Breast Cancer therapies - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Dana-Farber’s Breast Oncology Center is leading…
Dec 26, 2024, 15:50 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…
Dec 18, 2024, 13:50 | Blog
Proinflammatory Dietary Pattern and Risk of Total and Subtypes of Breast Cancer Among U.S. Women
Dana-Farber’s Breast Oncology Center shared on X: "New Study: Proinflammatory Dietary Pattern and Risk of Total…
Dec 17, 2024, 05:49 | Science
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center posted on X: "Check out the newest Breast Cancer Research Digest…
Dec 15, 2024, 08:38 | Blog
EMBER3 data in the context of other treatment options in ET-pretreated HR+/HER2- MBC
Paolo Tarantino, Working towards a PhD in clinical research at the University of Milan, shared…
Dec 14, 2024, 17:00 | Insight
Insights on PATINA trial from SABCS 2024
Pre-clinical data showed that CDK 4/6 inhibition plays a role in HER2+ disease. Phase 2…
Dec 14, 2024, 06:34 | Blog
Immediate Subsequent lines of therapy after T-DXd in Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "SABCS24 POSTER SESSION | P1-08-08 |…
Dec 13, 2024, 20:25 | Blog
Olga Kantor: Financial toxicity in young women with breast cancer at SABCS24
Olga Kantor, Breast Surgeon at Brigham and Women's Hospital, shared a post on X: “Important…
Dec 12, 2024, 20:39 | Blog
Ada Waks on the management of small HER2+ breast cancers
Paolo Tarantino shared on X: "Terrific talk on the management of small HER2+ breast cancers by…
Dec 11, 2024, 16:46 | Blog
Sara Tolaney: Start early, it takes lots of time
Dana-Farber’s Breast Oncology Center posted on X: "Dr. Sara Tolaney offered great tips and strategies for…
Dec 11, 2024, 16:25 | Blog
Guilherme Nader-Marta at the SABCS24 Poster Spotlight Session 2 - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Join Dr. Guilherme Nader-Marta at the SABCS24 Poster…
Dec 11, 2024, 09:20 | Blog
Meet Dr. Stefania Morganti - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Stefania Morganti, an Advanced…
Dec 8, 2024, 06:53 | Insight
The role of ADCs in the treatment of patients with Breast Cancer Brain Metastases - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X, about a recent paper by Stacey…
Nov 29, 2024, 15:31 | Insight
Thanksgiving Day 2024: A Time for Gratitude and Reflection
Thanksgiving Day in 2024 fell on November 28th. Thanksgiving Day is a national holiday celebrated…
Nov 26, 2024, 17:58 | Blog
Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI
Dana-Farber’s Breast Oncology Center shared a post on X: “We are leading a phase 2…
Nov 21, 2024, 15:07 | Insight
Consumption of aspartame and the risk of Breast Cancer in the Nurses' Health Studies
Dana-Farber’s Breast Oncology Center shared a post on X: “New study in JNCI from Dana-Farber’s…
Nov 18, 2024, 21:55 | Blog
Caterina Sposetti: New Oncologists from the University of Milan
Caterina Sposetti, Medical Oncology Fellow at Dana-Farber’s Breast Oncology Center and Dana-Farber Zakim Center, shared…
Nov 15, 2024, 17:45 | Insight
Osteopontin as a therapeutic target in Breast Cancer recurrence
A recent paper by Yu Gu, PhD Candidate at McGill University, was mentioned by Dana-Farber’s…
Nov 12, 2024, 18:59 | Insight
Dana-Farber’s Breast Cancer Research Digest
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the Breast Cancer Research Digest…
Nov 11, 2024, 18:23 | Blog
Patient Insights on Recurrence in Hormone Receptor-Positive Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a recent article by Shoshana M Rosenberg on X: "New article…
Nov 10, 2024, 16:37 | Insight
Incorporation of immunotherapy in the management of early-stage ER+ Breast Cancer
A recent paper by Guilherme Nader-Marta, Clinical Fellow at Dana-Farber Cancer Institute, was mentioned by…
Nov 10, 2024, 03:48 | Insight
Tracing 40 years of breakthroughs and challenges in ADC development
Dana-Farber’s Breast Oncology Center shared a post on X: “Don't miss this recently published Cancer…
Nov 8, 2024, 04:47 | Insight
ICIs for patients with metastatic triple-negative Inflammatory Breast Cancer
Dana-Farber’s Breast Oncology Center shared a post on X: “This just published international cohort study…
Nov 6, 2024, 14:55 | Insight
Dana Farber Cancer Institute’s 7th Annual Inflammatory Breast Cancer Patient Forum
Dana-Farber’s Breast Oncology Center shared a post on X: “Join us on Saturday November 9…
Nov 5, 2024, 01:27 | Career
Ashley Odai-Afotey to Research Health Equity in Cancer Pain Management and a Weight Loss intervention - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Ashley Odai-Afotey, an Olney/Silver…
Nov 3, 2024, 09:27 | Blog
Ilana Schlam: Excited to kick off my first day at Dana-Farber’s Breast Oncology Center
Ilana Schlam posted on X: "Excited to kick off my first day at Dana-Farber’s Breast…
Oct 29, 2024, 13:05 | Insight
Paolo Tarantino: My 100th scientific publication
Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "It turns out…
Oct 25, 2024, 11:48 | Blog
Paolo Tarantino: Anticipated evolutions in the assessment of MRD to guide cancer treatment
Paolo Tarantino shared a post on X: ''ENASymp24 day 3: Heather Parsons from Dana-Farber’s Breast…
Oct 17, 2024, 05:56 | Blog
Jun Mao: Amazing integrative medicine medical consult model of care Dana-Farber’s Breast Oncology Center
Jun Mao, Professor of Medicine at Weill Cornell Medicine, shared a post on X: “Seeing…
Oct 15, 2024, 19:00 | Insight
The use of TDXd for patients with Metastatic, HER2-low and HER2-ultralow Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out our newest treatment guideline…
Oct 14, 2024, 11:40 | Insight
Characteristics and clinical outcomes of Breast Cancer in young BRCA carriers
Dana-Farber’s Breast Oncology Center shared a post on X: “New study now out in ESMO…
Oct 12, 2024, 12:43 | Blog
The 7th Annual B-PREP Patient Forum - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join us on Sat, Oct 19th, 9…
Oct 12, 2024, 00:58 | Blog
SIO partner with Dana Farber Cancer Institute in hosting the 22nd SIO International Conference
Society for Integrative Oncology (SIO) shared on X: '' Save the date! SIO is excited to…
Oct 10, 2024, 09:30 | Blog
Elia Seguí, a new Advanced Fellow at the Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Elia Seguí, a new Advanced…
Oct 6, 2024, 16:57 | Blog
Sarah Sammons: Sound advice on how to help a friend with cancer
Sarah Sammons shared a post on X: "I am very lucky to know Renée and she…
Oct 4, 2024, 10:15 | Blog
The first prospective trial of sacituzimab govitecan (+ trastuzumab) after T-DXd for HER2+ MBC
Paolo Tarantino shared a post by Dana-Farber’s Breast Oncology Center on X, adding: "There’s few open questions as…
Oct 2, 2024, 14:56 | Insight
The most recent Breast Cancer Research Digest by Dana-Farber
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…
Oct 1, 2024, 17:18 | Blog
Paolo Tarantino: Feels like yesterday when I first stepped into Dana-Farber Cancer Institute
Paolo Tarantino shared a post on X: "It feels like yesterday when I first stepped…
Oct 1, 2024, 09:29 | Blog
Paolo Tarantino's ESMO24 top 5 breast cancer presentations and takeaway messages
Paolo Tarantino shared a post by Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, on X, adding:…
Sep 26, 2024, 16:19 | Blog
Antonio Giordano: Elevating value in cancer care
Antonio Giordano, President of Sbarro Health Research Organization, shared a post on X: ''Elevating value…
Sep 19, 2024, 12:03 | Insight
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: “Hot off the Press! Trastuzumab deruxtecan in HER2-positive…
Sep 16, 2024, 04:57 | Blog
ESMO24 symposium on the management of oligoprogressive disease - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: ''Don't miss special ESMO24 symposium on…
Sep 16, 2024, 04:57 | Blog
The latest insights on ADCs for HR-Positive, HER2-low metastatic breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: ''Paolo Tarantino will discuss the latest…
Sep 10, 2024, 14:58 | Insight
Adjuvant Endocrine Therapy Adherence in patients with breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "New: Effects of Adjuvant Endocrine Therapy-Specific…
Sep 10, 2024, 05:35 | Insight
Ann Partridge will receive the esteemed ESMO24 Award for her contribution to the development of medical oncology
Dana-Farber’s Breast Oncology Center shared on X: "Dr. Ann Partridge will receive the esteemed ESMO24…
Sep 2, 2024, 07:17 | Blog
The 2024 DF/HCC Breast Cancer Program Research Retreat - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Register today for the 2024 Dana-Farber/Harvard Cancer…
Aug 31, 2024, 16:48 | Blog
Tess O'Meara: Discussing mIF and machine learning imagine processing on breast cancer with Lajos Pustzai
Tess O'Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, shared a post on X: "Grateful to…
Aug 29, 2024, 03:12 | Blog
Jennifer Bellon on the role of radiation in Ductal Carcinoma In Situ at the annual DCIS Patient Forum
Dana-Farber’s Breast Oncology Center shared on X: "Check out the recording of Dr. Jennifer Bellon,…
Aug 27, 2024, 22:07 | Insight
Sarah Sammons: Expanding telehealth is a very important way to overcome disparities in healthcare access
Sarah Sammons shared a post on X: “Expanding telehealth is a very important way to…
Aug 18, 2024, 06:46 | Blog
The role of Breast Cancer related arm lymphedema in physical functioning among long-term African American breast cancer survivors
Dana-Farber’s Breast Oncology Center posted on X about paper by Sarah Nechuta et al., titled "The…
Aug 13, 2024, 09:53 | Blog
Ann Partridge is the recipient of the 2024 Casty Family Achievement in Mentoring Award
Dana-Farber’s Breast Oncology Center posted on X: "Congratulations to Dr. Ann Partridge who was selected…
Aug 8, 2024, 01:51 | Blog
Chiara Corti: Why Dana-Farber’s Breast Oncology Center is so special
Chiara Corti shared on X: “If a place is as good as the people u…
Aug 7, 2024, 19:44 | Blog
Erica Mayer and Rachel Freedman leading efforts to increase Diversity In Research - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "At  Dana Farber we are dedicated…
Jul 31, 2024, 11:56 | Insight
Dana-Farber’s Breast Oncology Center's newest Research Digest
Dana-Farber’s Breast Oncology Center shared on X: "Check out the newest Breast Cancer Research Digest…
Jul 31, 2024, 11:22 | Insight
Amal Arnaout discusses potential drug interactions of popular supplements - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: "Are Supplements Right For Me? Amal Arnaout discusses current…
Jul 25, 2024, 20:48 | Insight
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab in HER2+ Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: "New in JCO Oncology Practice: Subcutaneous vs Intravenous…
Jul 19, 2024, 09:21 | Blog
Day 2 at the Harvard Breast Cancer Course - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Day 2 at the Harvard Breast…
Jul 14, 2024, 06:24 | Blog
Dr. Paolo Tarantino reviewed key ongoing clinical trials at Harvard Breast Cancer Course - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:   . "Dr. Paolo Tarantino reviewed key…
Jul 8, 2024, 15:23 | Blog
Dana-Farber’s Breast Oncology Center - Breast Cancer Prognostic Staging System in AFT-01
Dana-Farber’s Breast Oncology Center shared on X: "Check out this recent publication in Annals of Surgical…
Jun 27, 2024, 15:09 | Blog
Treatment guideline for patients with a history of Breast Cancer who desire pregnancy - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: "Check out our newest consensus-based treatment guideline offering recommendations…
Jun 25, 2024, 13:37 | Insight
Sacituzumab govitecan with or without pembrolizumab in TNBC
The Dana-Farber’s Breast Oncology Center shared on X: "Dana-Farber’s Breast Oncology Center is leading a…
Jun 21, 2024, 10:34 | Blog
Trial on the use of Cold Caps in preventing hair loss with novel breast cancer therapies - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Dana-Farber’s Breast Oncology Center is leading…
Jun 21, 2024, 07:01 | Blog
This week's Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out this week's Breast Cancer…
Jun 16, 2024, 00:40 | Blog
Register for the Harvard Breast Course - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Register for the Harvard Breast Course!…
Jun 12, 2024, 03:50 | Blog
The most recent Breast Cancer Research Digest by Dana-Farber's Breast Oncology Center
Paolo Tarantino shared a post by Dana-Farber's Breast Oncology Center on X, adding the following: “Latest…
Jun 10, 2024, 02:20 | Blog
Paolo Tarantino: Great to welcome Dr. Abeid Athman for a fellowship at Dana-Farber’s Breast Oncology Center!
Paolo Tarantino shared a post on X: “Great to welcome Dr. Abeid Athman from Kenya for…
May 23, 2024, 10:28 | Blog
In a recent interview Dr. Erica Mayer discussed tamoxifen and aromatase inhibitors - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "In a recent Health Reporter interview…
May 21, 2024, 08:11 | Blog
Clinical trials for patients with Breast Cancer Brain Metastases by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “May is Brain Tumor Awarness Month and May 20th…
May 21, 2024, 07:50 | Insight
Daniel Stover: Honored to discuss 4 great breast cancer liquid biopsy abstracts with Heather Parsons at ASCO2024
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
12
All: 127 Posts: 1 - 100
Special Coverage